These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2706531

  • 1. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO, Lönnberg P, Marjamäki P, Rinne UK.
    Brain Res; 1989 Apr 03; 483(2):402-6. PubMed ID: 2706531
    [Abstract] [Full Text] [Related]

  • 2. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW, Wells FR, Jenner P, Marsden CD.
    J Neurochem; 1993 Jan 03; 60(1):197-203. PubMed ID: 8417140
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease.
    Shiozaki K, Iseki E, Uchiyama H, Watanabe Y, Haga T, Kameyama K, Ikeda T, Yamamoto T, Kosaka K.
    J Neurol Neurosurg Psychiatry; 1999 Aug 03; 67(2):209-13. PubMed ID: 10406992
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
    Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R.
    J Neurochem; 1992 Feb 03; 58(2):529-41. PubMed ID: 1729398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R.
    J Neurochem; 1988 Jun 03; 50(6):1914-23. PubMed ID: 3373218
    [Abstract] [Full Text] [Related]

  • 13. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S, Taniguchi T, Fujiwara M, Kameyama M.
    J Neurochem; 1986 Jan 03; 46(1):288-93. PubMed ID: 3940287
    [Abstract] [Full Text] [Related]

  • 14. Changes of muscarinic cholinergic binding by lymphocytes in Parkinson's disease with and without dementia.
    Rabey JM, Grynberg E, Graff E.
    Ann Neurol; 1991 Dec 03; 30(6):847-50. PubMed ID: 1789698
    [Abstract] [Full Text] [Related]

  • 15. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
    Flynn DD, Weinstein DA, Mash DC.
    Ann Neurol; 1991 Mar 03; 29(3):256-62. PubMed ID: 2042942
    [Abstract] [Full Text] [Related]

  • 16. A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.
    Wood PL, Etienne P, Lal S, Nair NP, Finlayson MH, Gauthier S, Palo J, Haltia M, Paetau A, Bird ED.
    J Neurol Sci; 1983 Dec 03; 62(1-3):211-7. PubMed ID: 6142096
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA, Ernste BH, Wester J, Kelder K.
    J Chem Neuroanat; 1988 Dec 03; 1(2):95-110. PubMed ID: 3267343
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.